Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Notes Payables (2016 - 2019)

Historic Notes Payables for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Q2 2019 value amounting to $48.8 million.

  • Ironwood Pharmaceuticals' Notes Payables rose 9627.93% to $48.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $48.8 million, marking a year-over-year increase of 9627.93%. This contributed to the annual value of $47.6 million for FY2018, which is N/A changed from last year.
  • As of Q2 2019, Ironwood Pharmaceuticals' Notes Payables stood at $48.8 million, which was up 9627.93% from $46.0 million recorded in Q1 2019.
  • In the past 5 years, Ironwood Pharmaceuticals' Notes Payables ranged from a high of $48.8 million in Q2 2019 and a low of $8.4 million during Q3 2016
  • Over the past 4 years, Ironwood Pharmaceuticals' median Notes Payables value was $25.0 million (recorded in 2015), while the average stood at $28.2 million.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Notes Payables crashed by 5822.77% in 2016, and later soared by 28435.36% in 2019.
  • Quarter analysis of 4 years shows Ironwood Pharmaceuticals' Notes Payables stood at $25.0 million in 2015, then crashed by 66.33% to $8.4 million in 2016, then surged by 465.78% to $47.6 million in 2018, then increased by 2.61% to $48.8 million in 2019.
  • Its Notes Payables was $48.8 million in Q2 2019, compared to $46.0 million in Q1 2019 and $47.6 million in Q4 2018.